Menu Close

Suramin & Autism: An Elite 100-Old Drug May Help Autistic Children

a white hand holding suramin vials.

In a remarkable discovery, researchers have found that Suramin (also known as Bayer 205, Antrypol, 309 Fourneau), an established drug with a history spanning over a century, holds potential in aiding children with autism (ASD). This unexpected revelation has sparked hope and excitement within the scientific community, as Suramin could provide a new avenue for the development of treatments for this complex neurodevelopmental disorder.

The Potential of Suramin:

Suramin, originally developed as an anti-parasitic medication, has been used for decades in the treatment of diseases such as African sleeping sickness. However, recent investigations have unveiled its surprising effects on ASD. In a pilot study conducted by a team of scientists, including Dr. Robert Naviaux from the University of California, San Diego, it demonstrated substantial improvements in core symptoms of the condition among participating children.

a vial suramin and box packaging

Effects on Autism Symptoms:

The study involved administering Suramin to a small group of boys diagnosed with autism spectrum disorder (ASD). The results were remarkable. The drug seemed to temporarily “reset” the brain, leading to significant improvements in language, social interaction, and restricted or repetitive behaviors—the hallmark characteristics of the condition.

READ MORE: Artificial Sweetener, Aspartame Could Be More Harmful to Your Brain Than You Think

Suramin and the Gut-Brain Connection in Autism:

The gut-brain connection is like a way for our stomach and brain to talk to each other. It turns out that what happens in our guts, where our food is broken down, can affect how our brains work, and vice versa.

Autism makes it hard for people to communicate and behave in certain ways. Scientists are trying to figure out why autism happens, and one idea they’re exploring is how the gut and the brain might be connected in people with autism.

Inside our gut, there are tiny living things called microbes that help with digestion and other important jobs. These microbes can make substances that influence our brain’s activity and behavior. Some studies have shown that the types of microbes in the gut might be different in people with autism.

One theory is that these microbes could produce chemicals that affect how our brain develops and how we behave. These chemicals might be different in people with autism, which could explain some of the differences in how they think and act.

The gut and the immune system, which helps us fight off illnesses, are also connected. Sometimes, people with autism have issues with their gut and immune system. These issues could send signals to the brain that affect how it works.

The connection between Microbiota, Gut, and Brain

A new study, called Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation show that our stomach has lots of nerve cells, creating a kind of second brain called the enteric nervous system. This “second brain” in our stomach is connected to our main brain by a nerve called the vagus nerve, forming a communication pathway known as the gut-brain axis. This pathway involves different parts of our nervous system, chemicals in our body, and our immune system working together.

Chemicals in our stomach, called neurotransmitters, affect how we feel emotionally. Many of these neurotransmitters, like serotonin, are made in our stomach. Our stomach also has a lot of bacteria, even more than our own body cells. These bacteria help with important things like breaking down food and keeping our stomach healthy. Some of these bacteria can turn food into chemicals that affect our mood and behavior. For example, one type of bacteria can change a part of our food into a chemical that helps us feel good.

However, there are also some bad bacteria that can cause problems in our stomach. Some of these bad bacteria, like Clostridium, might be connected to issues like autism. These bacteria can make harmful substances that affect how our brain works. Researchers are trying to understand more about how these bacteria can affect our brain and behavior, and they are looking for ways to use this knowledge to help with conditions like autism.

Mechanism of Action:

While the exact mechanism of Suramin’s action in treating the condition is not yet fully understood, researchers believe it may be related to the drug’s ability to modulate the purinergic system—a signaling pathway involved in numerous cellular functions. By blocking certain receptors and inhibiting the release of signaling molecules, it appears to restore normal communication between brain cells, allowing for improved cognitive and behavioral functioning.

The need for more study

Although the initial findings are promising, it is crucial to recognize that this was a small-scale pilot study. More extensive research involving larger cohorts and rigorous clinical trials is necessary to fully validate the efficacy and safety of Bayer 205 as an autism treatment. Researchers are actively working to unravel the underlying mechanisms, optimize dosing regimens, and identify potential long-term effects to ensure the drug’s suitability for pediatric use.

a boy child with autism closes his ears

A Collaborative Approach:

To advance the understanding of Suramin’s potential in treating autistic children, multidisciplinary collaborations are underway, bringing together researchers, clinicians, and pharmaceutical companies. This collaborative effort aims to accelerate the exploration of its therapeutic properties and pave the way for future treatment options for individuals with the condition.

Caution and Realistic Expectations:

While the preliminary results with Suramin are highly encouraging, it is essential to approach this discovery with caution and manage expectations. Autism is a complex disorder with a wide spectrum of symptoms and underlying causes, making it unlikely that it will be a universal solution for all individuals with the condition. However, it represents a significant step forward in uncovering potential avenues for personalized treatments tailored to specific subgroups within the community.

The emergence of the drug as a potentially transformative treatment for the condition brings newfound hope to families and individuals affected by this challenging condition. As research progresses, we inch closer to a deeper understanding of for the condition and the development of innovative therapies. While there is still much to learn and explore, the discovery of its positive impact on ASD symptoms offers a glimpse of a brighter future for those living with ASD.

From Pine Trees to Breakthrough Medicine: The Surprising Story of Suramin and Its Origins

How Suramin Started as a Dye and Became a Powerful Medicine

The powerful medicine called actually began its journey as a simple dye? Back in 1922, when it was first used to treat a disease called African sleeping sickness, it was a big deal. This medicine was one of the very first ways we found to fight infections. But how did it all start?

a bottle of trypan blue from which suramin is made

The Colorful Beginning: Trypan Blue and Its Origins

This story starts with something called trypan blue. It’s a type of dye that was made in 1904 by a scientist named Paul Ehrlich. Trypan blue got its name because it’s really good at killing tiny parasites that make people sick, especially the ones causing African sleeping sickness. But here’s where it gets interesting: trypan blue comes from another substance called toluidine, which is made from toluene. And guess what? Toluene is linked to pine oil.

A Connection to Pine Oil and a Special Discovery

Toluene, the stuff that’s part of the dye trypan, has a surprising connection to pine oil. Way back in 1837, a chemist named Filip Walter figured out how to make toluene by distilling pine oil. He even gave it a fancy name – rétinnaphte. This discovery set the stage for some amazing things to come.

Pine-Sol’s Piney Past and a Modern Change

You might have heard of Pine-Sol, a cleaning product that was all about the scent of pine. Back in the day, it was made using the oil and became really popular. But in recent times, things have changed. Pine-Sol doesn’t use pine oil in its recipe anymore, mainly to save money.

READ MORE: Adios Anodontia: Pioneering Human Tooth Regrowth Trials Begin

Bringing Back the Goodness: Pine Needle Tea

Now, let’s talk about pine needle tea. It’s a simple and old-fashioned way to enjoy the benefits of pine. Unlike strong distillation methods that can destroy some of the good stuff, pine tea gently takes out the helpful parts of the plant. It’s like a natural extract that keeps many of the plant’s nutrients intact.

pine oil which is extracted from pine needle, is an original ingredient from which suramin is made from.

The Big Picture: Connecting the Dots

So, what’s the big takeaway here? Suramin, the powerful medicine, has its roots in the colorful world of dyes and pine trees. From trypan blue to pine oil and Pine-Sol, it’s a story of discoveries and changes. And now, even in a cup of pine needle tea, we’re finding new ways to appreciate the goodness of pine. It’s a reminder that sometimes the simplest things can lead to groundbreaking breakthroughs.

How to Get Suramin in South Africa

Currently Suramin is not available in South Africa, however though, a medical company called PaxMedica wants to do a special test in South Africa. They’re asking for permission from a health agency, South African Health Products Regulatory Authority (SAHPRA), to try a new way to help kids with ASD using the drug, which they will put in the body through a tube in the veins.

They plan to test if this medicine is safe and if it really helps kids with ASD. They want to have 30 kids from South Africa try this medicine, and they will watch to see how it works.

The leader of PaxMedica, Howard Weisman, said they did a test before in 2021 and saw that the medicine helped boys with ASD. The kids got better, and it was safe for them. Now they want to do a bigger test to get more proof, and if it works well, they will do more tests in the US.

They hope to start testing at the end of this year if they get the permission. PaxMedica is also talking to other places to get permission for tests in those places too.

PaxMedica is making the special stuff they need for PAX-101, and they are almost done.

PaxMedica is also working with PoloMar Health to see if another medicine called emodin can also help with ASD.

Related Posts